Lantern Pharma (LTRN) Reports Q1 Loss of $0.51
Tweet
Share
E-mailGet Alerts LTRN Hot Sheet
Join SI Premium – FREE
Lantern Pharma (NASDAQ: LTRN) reported Q1 EPS of ($0.51).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
